Arcus Biosciences
Patents, Design & Utilities

Last updated:

List of all Arcus Biosciences patents 31 in total

Status Patent
Application
Utility: TREATMENT OF ONCOGENE-DRIVEN CANCERS External link
Filling date: 5 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS External link
Filling date: 5 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: TREATMENT OF CANCER UTILIZING AN IDENTIFIED ADENOSINE FINGERPRINT External link
Filling date: 5 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 12 May 2022
Grant
Utility: Inhibitors of CD73-mediated immunosuppression External link
Filling date: 5 Sep 2025 Issue date: 8 Mar 2022
Application
Utility: ANTIBODIES TO TIGIT External link
Filling date: 5 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: INHIBITORS OF ARG1 AND/OR ARG2 External link
Filling date: 5 Sep 2025 Issue date: 20 Jan 2022
Grant
Utility: Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders External link
Filling date: 5 Sep 2025 Issue date: 11 Jan 2022
Application
Utility: CRYSTALLINE FORMS OF A CD73 INHIBITOR AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: CD73 INHIBITORS External link
Filling date: 5 Sep 2025 Issue date: 11 Nov 2021
Application
Utility: TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA External link
Filling date: 5 Sep 2025 Issue date: 14 Oct 2021
Application
Utility: SOLID FORMS OF AN AZOLOPYRIMIDINE COMPOUND External link
Filling date: 5 Sep 2025 Issue date: 2 Sep 2021
Grant
Utility: Azolopyrimidine for the treatment of cancer-related disorders External link
Filling date: 5 Sep 2025 Issue date: 27 Jul 2021
Application
Utility: QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 15 Jul 2021
Grant
Utility: Inhibitors of adenosine 5'-nucleotidase External link
Filling date: 5 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Quinazoline-pyridine derivatives for the treatment of cancer-related disorders External link
Filling date: 5 Sep 2025 Issue date: 29 Jun 2021
Application
Utility: PYRIDONE A2R ANTAGONISTS External link
Filling date: 5 Sep 2025 Issue date: 3 Jun 2021
Grant
Utility: Modulators of 5'-nucleotidase, ecto and the use thereof External link
Filling date: 5 Sep 2025 Issue date: 11 May 2021
Grant
Utility: Modulators of 5'-nucleotidase, ecto and the use thereof External link
Filling date: 5 Sep 2025 Issue date: 20 Apr 2021
Application
Utility: AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 7 Jan 2021
Application
Utility: ARGINASE INHIBITORS External link
Filling date: 5 Sep 2025 Issue date: 7 Jan 2021
Application
Utility: PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS External link
Filling date: 5 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: DOSING WITH AN AZOLOPYRIMIDINE COMPOUND External link
Filling date: 5 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE External link
Filling date: 5 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS External link
Filling date: 5 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: INHIBITORS OF CD73-MEDIATED IMMUNOSUPPRESSION External link
Filling date: 5 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF External link
Filling date: 5 Sep 2025 Issue date: 10 Oct 2019
Grant
Utility: Azolopyrimidine for the treatment of cancer-related disorders External link
Filling date: 5 Sep 2025 Issue date: 3 Sep 2019

Showing 1 to 31 of 31 patents.